Conjugates, their compositions, their uses, and their methods of making
US-2019106473-A1 · Apr 11, 2019 · US
Octapeptide compounds and therapeutic use thereof
US9040482B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9040482-B2 |
| Application number | US-201113806510-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 21, 2011 |
| Priority date | Jun 22, 2010 |
| Publication date | May 26, 2015 |
| Grant date | May 26, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to novel octapeptide compounds of general formula (I), R-AA 1 -cyclo(AA 2 -Tyr 3 -D-Trp 4 -AA 5 -Val 6 -Cys 7 )-Thr 8 -NH 2 (I) As these products have a good affinity for certain sub-types of somatostatin receptors, they are particularly useful for treating the pathological states or diseases in which one (or more) of the somatostatin receptors is (are) involved. The invention also relates to pharmaceutical compositions containing said products and their use for the preparation of a medicament.
First claim
Opening claim text (preview).
The invention claimed is: 1. An octapeptide compound of general formula (I) R-AA 1 -cyclo(AA 2 -Tyr 3 -D-Trp 4 -AA 5 -Val 6 -Cys 7 )-Thr 8 -NH 2 (I) wherein (i) AA 1 represents an amino acid radical linked to the radical R and to the amino acid AA 2 according to the formula wherein R1 represents a naphthyl radical optionally substituted by…
Assignees
Inventors
Classifications
- C07K14/655Primary
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9040482B2 cover?
- The present invention relates to novel octapeptide compounds of general formula (I), R-AA 1 -cyclo(AA 2 -Tyr 3 -D-Trp 4 -AA 5 -Val 6 -Cys 7 )-Thr 8 -NH 2 (I) As these products have a good affinity for certain sub-types of somatostatin receptors, they are particularly useful for treating the pathological states or diseases in which one (or more) of the somatostatin receptors is (are) invol…
- Who is the assignee on this patent?
- Cintrat Jean-Christophe, Ligeti Melinda, Rousseau Bernard, and 9 more
- What technology area does this patent fall under?
- Primary CPC classification C07K14/655. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).